Valuation Integra LifeSciences Holdings Corporation
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
14:36:41 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 12.11 USD | +2.28% |
|
-11.01% | -3.06% |
Company Valuation: Integra LifeSciences Holdings Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,674 | 4,683 | 3,405 | 1,750 | 967.4 | 920.8 | - | - |
| Change | - | -17.47% | -27.3% | -48.6% | -44.72% | -4.82% | - | - |
| Enterprise Value (EV) 1 | 6,707 | 5,670 | 4,605 | 3,285 | 2,563 | 3,009 | 2,218 | 2,027 |
| Change | - | -15.47% | -18.78% | -28.66% | -21.98% | 17.39% | -26.29% | -8.59% |
| P/E | 33.8x | 26x | 51.8x | -252x | -1.84x | 23.1x | 10.9x | 8.86x |
| PBR | 3.37x | 2.6x | 2.14x | 1.13x | 0.93x | 1.6x | 0.71x | 0.64x |
| PEG | - | 2.86x | -0.8x | 2x | -0x | -0x | 0x | 0.4x |
| Capitalization / Revenue | 3.68x | 3.01x | 2.21x | 1.09x | 0.59x | 0.56x | 0.55x | 0.53x |
| EV / Revenue | 4.35x | 3.64x | 2.99x | 2.04x | 1.57x | 1.83x | 1.32x | 1.16x |
| EV / EBITDA | 16.7x | 13.8x | 12.5x | 10.2x | 8.07x | 9.37x | 6.42x | 5.53x |
| EV / EBIT | 21.4x | 15.5x | 14x | 11.7x | 9.33x | 10.8x | 7.33x | 6.21x |
| EV / FCF | 25.4x | 25.5x | 63x | 132x | -82.5x | 23.9x | 12.4x | 13.7x |
| FCF Yield | 3.94% | 3.92% | 1.59% | 0.76% | -1.21% | 4.19% | 8.09% | 7.28% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.98 | 2.16 | 0.84 | -0.09 | -6.74 | 0.5125 | 1.09 | 1.337 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,542 | 1,558 | 1,542 | 1,611 | 1,635 | 1,647 | 1,680 | 1,744 |
| EBITDA 1 | 400.7 | 411.3 | 369.7 | 322.2 | 317.5 | 321 | 345.3 | 366.5 |
| EBIT 1 | 314.1 | 366.6 | 329.1 | 281.1 | 274.8 | 277.4 | 302.5 | 326.3 |
| Net income 1 | 169.1 | 180.6 | 67.74 | -6.944 | -516.5 | 35.57 | 69.57 | 88.23 |
| Net Debt 1 | 1,033 | 986.7 | 1,200 | 1,535 | 1,596 | 2,088 | 1,297 | 1,106 |
| Reference price 2 | 66.99 | 56.07 | 43.55 | 22.68 | 12.42 | 11.84 | 11.84 | 11.84 |
| Nbr of stocks (in thousands) | 84,700 | 83,518 | 78,176 | 77,164 | 77,892 | 77,773 | - | - |
| Announcement Date | 2/23/22 | 2/22/23 | 2/28/24 | 2/25/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.27x | 1.46x | 7.47x | -.--% | 921M | ||
| 29.59x | 3.89x | 15.41x | 2.56% | 174B | ||
| 23.21x | 4.54x | 15.84x | 1.21% | 114B | ||
| 19.89x | 3.46x | 12.4x | 3.05% | 114B | ||
| 30.39x | 2.95x | 11.92x | 2.36% | 89.64B | ||
| 18.67x | 0.21x | 13.47x | 0.7% | 64.96B | ||
| 31.91x | 8x | 20.56x | 1.24% | 56.09B | ||
| 38.54x | 3.57x | 12.15x | 2.04% | 52.94B | ||
| 37.48x | 9.31x | 26.04x | -.--% | 43.6B | ||
| 39.32x | 3.19x | 11.88x | 0.55% | 32.77B | ||
| Average | 29.03x | 4.06x | 14.71x | 1.37% | 74.29B | |
| Weighted average by Cap. | 27.96x | 4.06x | 15.04x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IART Stock
- Valuation Integra LifeSciences Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
















